SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
04-Mar-24 5:25 PM View: | Milano Vincent Director | BioCryst Pharmaceuticals Inc. (BCRX) | 29-Feb-24 | Grant | 999 | $5.63 | $5,624.37 | 2% 51.0K to 52.0K | |
04-Mar-24 4:32 PM View: | Heggie Theresa Director | BioCryst Pharmaceuticals Inc. (BCRX) | 29-Feb-24 | Grant | 999 | $5.63 | $5,624.37 | 2% 50.86K to 51.86K | |
04-Jan-24 4:31 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 03-Jan-24 | Gift | 20,000 | -- | -- | (2%) 1.15M to 1.13M | |
04-Jan-24 4:31 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 03-Jan-24 | Gift | 20,000 | -- | -- | 2% 1.13M to 1.15M | |
20-Dec-23 4:42 PM View: | Thackray Helen M. Chief R&D Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 5,580 | $6.05 | $33,759.00 | (2%) 255.24K to 249.66K | |
20-Dec-23 4:38 PM View: | Gayer Charles K Chief Commercial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 2,482 | $6.05 | $15,016.10 | (< 1%) 277.01K to 274.53K | |
20-Dec-23 4:35 PM View: | Doyle Anthony Chief Financial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 2,482 | $6.05 | $15,016.10 | (1%) 229.93K to 227.44K | |
20-Dec-23 4:40 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 14,089 | $6.05 | $85,238.50 | (1%) 1.15M to 1.13M | |
20-Dec-23 4:33 PM View: | Barnes Alane P Chief Legal Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 2,482 | $6.05 | $15,016.10 | (< 1%) 296.02K to 293.54K | |
18-Dec-23 4:40 PM View: | Gayer Charles K Chief Commercial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 5,840 | $6.43 | $37,551.20 | (2%) 282.86K to 277.01K | |
18-Dec-23 4:37 PM View: | Doyle Anthony Chief Financial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 5,475 | $6.43 | $35,204.20 | (2%) 235.4K to 229.93K | |
18-Dec-23 4:43 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 13,592 | $6.43 | $87,396.60 | (1%) 1.16M to 1.15M | |
18-Dec-23 4:34 PM View: | Barnes Alane P Chief Legal Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 64,000 | -- | -- | 27% 236.04K to 300.04K | |
18-Dec-23 4:34 PM View: | Barnes Alane P Chief Legal Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 4,015 | $6.43 | $25,816.40 | (1%) 300.04K to 296.02K | |
18-Dec-23 4:47 PM View: | Thackray Helen M. Chief R&D Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 51,000 | -- | -- | 25% 207.28K to 258.27K | |
18-Dec-23 4:40 PM View: | Gayer Charles K Chief Commercial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 34,000 | -- | -- | 14% 248.85K to 282.86K | |
18-Dec-23 4:37 PM View: | Doyle Anthony Chief Financial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 34,000 | -- | -- | 17% 201.4K to 235.4K | |
18-Dec-23 4:43 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 127,500 | -- | -- | 12% 1.03M to 1.16M | |
18-Dec-23 4:47 PM View: | Thackray Helen M. Chief R&D Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 3,031 | $6.43 | $19,489.30 | (1%) 258.27K to 255.24K | |
01-Dec-23 4:40 PM View: | Heggie Theresa Director | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-23 | Grant | 956 | $5.88 | $5,621.28 | 2% 49.91K to 50.86K | |
01-Dec-23 4:42 PM View: | Milano Vincent Director | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-23 | Grant | 956 | $5.88 | $5,621.28 | 2% 50.04K to 51.0K | |
05-Sep-23 4:43 PM View: | Milano Vincent Director | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Aug-23 | Grant | 791 | $7.11 | $5,624.01 | 2% 49.25K to 50.04K | |
05-Sep-23 4:41 PM View: | Heggie Theresa Director | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Aug-23 | Grant | 791 | $7.11 | $5,624.01 | 2% 49.11K to 49.91K | |
15-Jun-23 4:37 PM View: | Sanders MacHelle Director | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Jun-23 | Sale | 4,000 | $7.98 | $31,920.00 | (14%) 29.61K to 25.61K | |
15-Jun-23 4:33 PM View: | Hutson Nancy J Director | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Jun-23 | Sale | 12,866 | $8.04 | $103,443.00 | (14%) 94.68K to 81.82K | |
15-Jun-23 4:37 PM View: | Sanders MacHelle Director | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 130% 12.87K to 29.61K | |
15-Jun-23 4:35 PM View: | Milano Vincent Director | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 52% 32.51K to 49.25K | |
15-Jun-23 4:50 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Gift | 25,000 | -- | -- | (2%) 1.06M to 1.03M | |
15-Jun-23 4:42 PM View: | Lee Kenneth B Jr Director | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 32% 52.12K to 68.86K | |
15-Jun-23 4:39 PM View: | Aselage Steve Director | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 36% 46.59K to 63.34K | |
15-Jun-23 4:33 PM View: | Hutson Nancy J Director | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 21% 77.94K to 94.68K | |
15-Jun-23 4:29 PM View: | Heggie Theresa Director | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 52% 32.37K to 49.11K | |
15-Jun-23 4:31 PM View: | McKee Amy E Director | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 130% 12.87K to 29.61K | |
15-Jun-23 4:28 PM View: | Abercrombie George B Director | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 130% 12.87K to 29.61K | |
15-Jun-23 4:43 PM View: | Levin Alan G Director | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 82% 20.34K to 37.09K | |
15-Jun-23 4:40 PM View: | Galson Steven K Director | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 130% 12.87K to 29.61K | |
02-Jun-23 4:32 PM View: | Heggie Theresa Director | BioCryst Pharmaceuticals Inc. (BCRX) | 31-May-23 | Grant | 680 | $8.27 | $5,623.60 | 2% 31.69K to 32.37K | |
02-Jun-23 4:34 PM View: | Levin Alan G Director | BioCryst Pharmaceuticals Inc. (BCRX) | 31-May-23 | Grant | 1,360 | $8.27 | $11,247.20 | 7% 18.98K to 20.34K | |
02-Jun-23 4:36 PM View: | Milano Vincent Director | BioCryst Pharmaceuticals Inc. (BCRX) | 31-May-23 | Grant | 680 | $8.27 | $5,623.60 | 2% 31.83K to 32.51K | |
05-Apr-23 4:33 PM View: | Thackray Helen M. Chief R&D Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 03-Apr-23 | Sale (Planned) | 7,000 | $8.29 | $58,030.00 | (3%) 214.28K to 207.28K | |
23-Mar-23 4:40 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 21-Mar-23 | Option Exercise | 31,055 | $3.22 | $99,997.10 | 3% 1.03M to 1.06M | |
02-Mar-23 4:37 PM View: | Levin Alan G Director | BioCryst Pharmaceuticals Inc. (BCRX) | 28-Feb-23 | Grant | 1,271 | $8.85 | $11,248.40 | 7% 17.71K to 18.98K | |
02-Mar-23 4:44 PM View: | Milano Vincent Director | BioCryst Pharmaceuticals Inc. (BCRX) | 28-Feb-23 | Grant | 635 | $8.85 | $5,619.75 | 2% 31.19K to 31.83K | |
02-Mar-23 4:38 PM View: | Heggie Theresa Director | BioCryst Pharmaceuticals Inc. (BCRX) | 28-Feb-23 | Grant | 635 | $8.85 | $5,619.75 | 2% 31.05K to 31.69K | |
02-Mar-23 4:41 PM View: | Ingram Robert Alexander Director | BioCryst Pharmaceuticals Inc. (BCRX) | 28-Feb-23 | Grant | 2,259 | $8.85 | $19,992.20 | 2% 97.94K to 100.2K | |
02-Feb-23 5:20 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Feb-23 | Option Exercise | 100,000 | $5.45 | $545,000.00 | 10% 1.03M to 1.13M | |
02-Feb-23 5:20 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Feb-23 | Planned Option Sale | 100,000 | $10.38 | $1,038,000.00 | (9%) 1.13M to 1.03M | |
02-Feb-23 5:15 PM View: | Lee Kenneth B Jr Director | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Jan-23 | Option Exercise | 15,000 | $1.71 | $25,650.00 | 40% 37.12K to 52.12K | |
02-Feb-23 5:20 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 29-Dec-22 | Gift | 10,000 | -- | -- | < 1% 1.03M to 1.04M | |
02-Feb-23 5:20 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 29-Dec-22 | Gift | 10,000 | -- | -- | (< 1%) 1.04M to 1.03M |